Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-07-07 20:53:57 UTC |
---|
HMDB ID | HMDB0000172 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Isoleucine |
---|
Description | Isoleucine (Ile) or L-isoleucine is an alpha-amino acid. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Amino acids are organic compounds that contain amino (-NH2) and carboxyl (-COOH) functional groups, along with a side chain (R group) specific to each amino acid. L-isolecuine is one of 20 proteinogenic amino acids, i.e., the amino acids used in the biosynthesis of proteins. Isoleucine is found in all organisms ranging from bacteria to plants to animals. It is classified as a non-polar, uncharged (at physiological pH) aliphatic amino acid. Isoleucine is an essential amino acid in humans, meaning the body cannot synthesize it and that it must be obtained from the diet. In plants and microorganisms, isoleucine is synthesized starting from pyruvate and alpha-ketobutyrate. Isoleucine is classified as a branched chain amino acid (BCAA). BCAAs include three amino acids: isoleucine, leucine and valine. They are alpha amino acids whose carbon structure is marked by a beta branch point. Despite their structural similarities, BCAAs have different metabolic routes, with valine going solely to carbohydrates (glucogenic), leucine solely to fats (ketogenic) and isoleucine being both a glucogenic and a ketogenic amino acid. Isoleucine is catabolized via with alpha-ketoglutarate where upon it is oxidized and split into propionyl-CoA and acetyl-CoA. Propionyl-CoA is converted into succinyl-CoA, a TCA cycle intermediate which can be converted into oxaloacetate for gluconeogenesis (hence glucogenic). The acetyl-CoA can be fed into the TCA cycle by condensing with oxaloacetate to form citrate or used in the synthesis of ketone bodies or fatty acids. The different metabolism of BCAAs accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine and isoleucine are required respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. BCAAs are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia. An inability to break down isoleucine, along with other amino acids, is associated with maple syrup urine disease (MSUD) (PMID: 34125801 ). Isoleucine, like other BCAAs, is associated with insulin resistance. In particular, higher levels of isoleucine are observed in the blood of diabetic mice, rats, and humans (PMID 25287287 ). Mice fed an isoleucine deprivation diet for one day have improved insulin sensitivity, and feeding of an isoleucine deprivation diet for one week significantly decreases blood glucose levels (PMID: 24684822 ). |
---|
Structure | InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(2S,3S)-2-Amino-3-methylpentanoic acid | ChEBI | 2-Amino-3-methylvaleric acid | ChEBI | alpha-Amino-beta-methylvaleric acid | ChEBI | I | ChEBI | Ile | ChEBI | ISOLEUCINE | ChEBI | (2S,3S)-2-Amino-3-methylpentanoate | Generator | 2-Amino-3-methylvalerate | Generator | a-Amino-b-methylvalerate | Generator | a-Amino-b-methylvaleric acid | Generator | alpha-Amino-beta-methylvalerate | Generator | Α-amino-β-methylvalerate | Generator | Α-amino-β-methylvaleric acid | Generator | (2S,3S)-2-Amino-3-methyl-pentanoate | HMDB | (2S,3S)-2-Amino-3-methyl-pentanoic acid | HMDB | (2S,3S)-a-Amino-b-methyl-N-valerate | HMDB | (2S,3S)-a-Amino-b-methyl-N-valeric acid | HMDB | (2S,3S)-a-Amino-b-methylvalerate | HMDB | (2S,3S)-a-Amino-b-methylvaleric acid | HMDB | (2S,3S)-Alph-amino-beta-methylvalerate | HMDB | (2S,3S)-Alph-amino-beta-methylvaleric acid | HMDB | (2S,3S)-alpha-Amino-beta-merthyl-N-valerate | HMDB | (2S,3S)-alpha-Amino-beta-merthyl-N-valeric acid | HMDB | (2S,3S)-alpha-Amino-beta-merthylvalerate | HMDB | (2S,3S)-alpha-Amino-beta-merthylvaleric acid | HMDB | (2S,3S)-alpha-Amino-beta-methyl-N-valerate | HMDB | (2S,3S)-alpha-Amino-beta-methyl-N-valeric acid | HMDB | (2S,3S)-alpha-Amino-beta-methylvalerate | HMDB | (2S,3S)-alpha-Amino-beta-methylvaleric acid | HMDB | (S)-Isoleucine | HMDB | (S,S)-Isoleucine | HMDB | 2-Amino-3-methylpentanoate | HMDB | 2-Amino-3-methylpentanoic acid | HMDB | 2S,3S-Isoleucine | HMDB | Erythro-L-isoleucine | HMDB | Iso-leucine | HMDB | L-(+)-Isoleucine | HMDB | L-Ile | HMDB | [S-(R*,r*)]-2-amino-3-methylpentanoate | HMDB | [S-(R*,r*)]-2-amino-3-methylpentanoic acid | HMDB | Isoleucine, L-isomer | HMDB | Alloisoleucine | HMDB | Isoleucine, L isomer | HMDB | L-Isomer isoleucine | HMDB | 2S-Amino-3S-methylpentanoate | HMDB | L-Isoleucine | KEGG |
|
---|
Chemical Formula | C6H13NO2 |
---|
Average Molecular Weight | 131.1729 |
---|
Monoisotopic Molecular Weight | 131.094628665 |
---|
IUPAC Name | (2S,3S)-2-amino-3-methylpentanoic acid |
---|
Traditional Name | L-isoleucine |
---|
CAS Registry Number | 73-32-5 |
---|
SMILES | CC[C@H](C)[C@H](N)C(O)=O |
---|
InChI Identifier | InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1 |
---|
InChI Key | AGPKZVBTJJNPAG-WHFBIAKZSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as isoleucine and derivatives. Isoleucine and derivatives are compounds containing isoleucine or a derivative thereof resulting from reaction of isoleucine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Isoleucine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Isoleucine or derivatives
- Alpha-amino acid
- L-alpha-amino acid
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty acid
- Fatty acyl
- Amino acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic oxide
- Organopnictogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | Biological locationSourceExogenous- Exogenous (HMDB: HMDB0000172)
FoodAnimal originHerb and spiceVegetableFruitNutCereal and cereal productPulseGourdCoffee and coffee productSoyTeaDishBaking goodBeverageAquatic originEggConfectioneryMilk and milk productOther milk productFermented milkFermented milk productUnfermented milk- Milk (Other mammals) (FooDB: FOOD00690)
- Milk (Human) (FooDB: FOOD00666)
- Milk (Cow) (FooDB: FOOD00618)
- Cow milk, pasteurized, vitamin A + D added, 0% fat (FooDB: FOOD00889)
- Cow milk, pasteurized, vitamin A + D added, 1% fat (FooDB: FOOD00890)
- Cow milk, pasteurized, vitamin A + D added, 2% fat (FooDB: FOOD00891)
- Cow milk, pasteurized, vitamin D added, 3.25% fat (FooDB: FOOD00892)
Fat and oilCocoa and cocoa productBaby foodUnclassified food or beverageSnack
|
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 285.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 35 mg/mL | Human Metabolome Project | LogP | -1.70 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
L-Isoleucine,1TMS,isomer #1 | CC[C@H](C)[C@H](N)C(=O)O[Si](C)(C)C | 1180.4 | Semi standard non polar | 33892256 | L-Isoleucine,1TMS,isomer #2 | CC[C@H](C)[C@H](N[Si](C)(C)C)C(=O)O | 1292.1 | Semi standard non polar | 33892256 | L-Isoleucine,2TMS,isomer #1 | CC[C@H](C)[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1316.6 | Semi standard non polar | 33892256 | L-Isoleucine,2TMS,isomer #1 | CC[C@H](C)[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1308.4 | Standard non polar | 33892256 | L-Isoleucine,2TMS,isomer #1 | CC[C@H](C)[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1419.5 | Standard polar | 33892256 | L-Isoleucine,2TMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1480.8 | Semi standard non polar | 33892256 | L-Isoleucine,2TMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1322.9 | Standard non polar | 33892256 | L-Isoleucine,2TMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1511.7 | Standard polar | 33892256 | L-Isoleucine,3TMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1501.3 | Semi standard non polar | 33892256 | L-Isoleucine,3TMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1434.9 | Standard non polar | 33892256 | L-Isoleucine,3TMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1401.2 | Standard polar | 33892256 | L-Isoleucine,1TBDMS,isomer #1 | CC[C@H](C)[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1396.9 | Semi standard non polar | 33892256 | L-Isoleucine,1TBDMS,isomer #2 | CC[C@H](C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O | 1519.3 | Semi standard non polar | 33892256 | L-Isoleucine,2TBDMS,isomer #1 | CC[C@H](C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1749.9 | Semi standard non polar | 33892256 | L-Isoleucine,2TBDMS,isomer #1 | CC[C@H](C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1724.7 | Standard non polar | 33892256 | L-Isoleucine,2TBDMS,isomer #1 | CC[C@H](C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1722.9 | Standard polar | 33892256 | L-Isoleucine,2TBDMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1878.2 | Semi standard non polar | 33892256 | L-Isoleucine,2TBDMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1758.8 | Standard non polar | 33892256 | L-Isoleucine,2TBDMS,isomer #2 | CC[C@H](C)[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1750.4 | Standard polar | 33892256 | L-Isoleucine,3TBDMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2161.4 | Semi standard non polar | 33892256 | L-Isoleucine,3TBDMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2055.1 | Standard non polar | 33892256 | L-Isoleucine,3TBDMS,isomer #1 | CC[C@H](C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1828.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0a4i-0930000000-e78f845bb2a8d4736476 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0a4i-0910000000-de9162d149073d0e2a37 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-0a4i-0920000000-599e61f8ccdb6525c7a9 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-0a4i-0910000000-742e44c426c0d6c2a9ac | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (2 TMS) | splash10-05fr-8910000000-dbb33e0f02ac2ca5fedd | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine EI-B (Non-derivatized) | splash10-0a4i-0920000000-37690f426455ac41e2c2 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Non-derivatized) | splash10-0a4i-0930000000-e78f845bb2a8d4736476 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Non-derivatized) | splash10-0a4i-0910000000-de9162d149073d0e2a37 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Non-derivatized) | splash10-0a4i-0920000000-599e61f8ccdb6525c7a9 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Non-derivatized) | splash10-0a4i-0910000000-742e44c426c0d6c2a9ac | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-QQ (Non-derivatized) | splash10-0udi-2392000000-74cca1eb265b8e3d7f43 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Non-derivatized) | splash10-05fr-8910000000-dbb33e0f02ac2ca5fedd | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Non-derivatized) | splash10-000i-9100000000-27891dff695c5db53796 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - Isoleucine GC-EI-TOF (Non-derivatized) | splash10-0a4i-0910000000-43ec1890f6dbd6aea657 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isoleucine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00b9-9100000000-40bc9ef43da5f18be883 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isoleucine GC-MS (1 TMS) - 70eV, Positive | splash10-000i-9200000000-ae8694c0f3e4dcc608f9 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isoleucine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isoleucine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isoleucine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isoleucine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-004r-9000000000-34d4d4cb7042da231eb4 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-000i-9300000000-8a23b3e62231eb65f80f | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-00ko-9000000000-ac7e71578d7e1d0e8ce9 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-052f-9000000000-2586d4a089921dd977ed | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-001i-0900000000-5b11521ff6a631376d2b | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-000i-9000000000-3c352f229e4067fcd489 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-000i-9000000000-8a7ef48fc0c1b6f845c2 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0002-0920000000-2e11aa1c7a5defc386db | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-001i-0900000000-b63ac9cf06eda4c54a81 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-000i-9000000000-e5b0c8c6b09f541d6dbf | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-000i-9000000000-d89d16d5c2242e44ec63 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-000i-9000000000-5de583142c7bdb381c8f | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-001i-0900000000-8c75bde35c4a4073ee65 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-001i-0900000000-233a9862f616afea2d17 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-001i-1900000000-375f35065b82b13e6d6e | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-00dl-9000000000-d0d4a9f90fe2aca74483 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-0006-9000000000-0018f47571feaf232ff8 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-001r-7900000000-278dc67396114be331ba | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-000i-9000000000-e26c042aa6231eeca071 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-014r-9000000000-b6c1752fd3fbccb3d1c5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-05mo-9000000000-0569c3162621252ed0a8 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-052f-9000000000-3d52b5d56d3fab45276e | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isoleucine CE-ESI-TOF (CE-system connected to 6210 Time-of-Flight MS, Agilent) , Positive-QTOF | splash10-001i-0900000000-720554d58264a9cfdb67 | 2012-08-31 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isoleucine 10V, Positive-QTOF | splash10-0019-9500000000-00268b2694cde281641b | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isoleucine 20V, Positive-QTOF | splash10-000i-9000000000-4014793e17e0290790a4 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isoleucine 40V, Positive-QTOF | splash10-0a4i-9000000000-eb9a97a14461e524e76e | 2016-09-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+H]+) | 2022-02-11 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|